Galmed Pharmaceuticals (EOCN) Return on Assets [ROA] (2014 - 2026)
Galmed Pharmaceuticals' Return on Assets [ROA] was 48.07% in Q2 2026, up 40.44 percentage points from 7.63% a year earlier and up 37.93 percentage points from the prior quarter.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Return on Assets [ROA] (2014 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Galmed Pharmaceuticals came in at 104.67%, up 19.12 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of +60.60 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was 85.55% in FY2024 (+45.65 pp), 39.90% in FY2023 (-29.47 pp), 69.37% in FY2022 (-4.60 pp) and 73.97% in FY2021 (+29.91 pp).
- The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q2 2023.
- Compared with a year earlier, Return on Assets [ROA] was higher in two of the last six quarters, with an average year-over-year change of -11.47 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2023 (a gain of 61.79 percentage points); the worst was Q1 2024 (a drop of 113.40 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Galmed Pharmaceuticals | 406,071.97 | 406,071.97 | - | 48.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.07% |
| Mar 31, 2026 | 10.15% |
| Jun 30, 2025 | 7.63% |
| Mar 31, 2025 | 1.91% |
| Dec 31, 2024 | 3.47% |
| Sep 30, 2024 | 35.34% |
| Jun 30, 2024 | 40.60% |
| Mar 31, 2024 | 39.60% |
| Dec 31, 2023 | 38.64% |
| Sep 30, 2023 | 47.01% |
| Jun 30, 2023 | 153.30% |
| Mar 31, 2023 | 152.99% |
| Dec 31, 2022 | 98.53% |
| Sep 30, 2022 | 105.66% |
| Jun 30, 2022 | 97.20% |
| Mar 31, 2022 | 91.21% |
| Dec 31, 2021 | 81.36% |
| Sep 30, 2021 | 73.39% |
| Jun 30, 2021 | 61.89% |
| Mar 31, 2021 | 55.42% |
API Access
Galmed Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();